ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $150,000 | +27.1% | 3,229 | -33.7% | 0.00% | 0.0% |
| Q1 2019 | $118,000 | +34.1% | 4,870 | -20.2% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | +29.4% | 6,105 | +39.2% | 0.00% | 0.0% |
| Q3 2018 | $68,000 | +750.0% | 4,385 | +908.0% | 0.00% | – |
| Q2 2018 | $8,000 | -57.9% | 435 | -63.0% | 0.00% | – |
| Q1 2018 | $19,000 | +850.0% | 1,175 | +571.4% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 175 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 175 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 175 | -63.2% | 0.00% | – |
| Q1 2017 | $5,000 | +150.0% | 475 | +171.4% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 175 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -85.7% | 175 | -92.0% | 0.00% | – |
| Q2 2016 | $7,000 | – | 2,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |